8
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T11016 | DGAT-1 inhibitor 2 | Transferase | |
DGAT-1 inhibitor 2 is an effective DGAT-1 inhibitor; anti-obesity drug. Objective: DGAT-1 acyl-CoA: diacylglycerol acyltransferase 1 (DGAT1) is one of two known DGAT enzymes that catalyze the final step of triglyceride s... | |||
T4681 | T863 | DGAT-3,DGAT-1 inhibitor | Acyltransferase , Transferase |
T-863(DGAT-1 inhibitor) is an orally active, selective and potent DGAT1 (Acyl-CoA:diacylglycerol acyltransferase 1) inhibitor that interacts with the acyl-CoA binding site of DGAT1, and inhibits triacylglycerol synthesis... | |||
T6365 | A 922500 | A922500,DGAT-1 Inhibitor 4a | Acyltransferase , Transferase |
A 922500 (DGAT-1 Inhibitor 4a) is an inhibitor for human and mouse DGAT-1 with IC50 of 7 nM and 24 nM, respectively, good selectivity over related acyltransferases, hERG, and a panel of anti-targets. | |||
T15109 | DGAT1-IN-1 | Transferase | |
DGAT1-IN-1 is a potent inhibitor of diacylglycerol O- acyltransferase type 1(DGAT1, IC50 of < 10 nM). | |||
T14375 | AZD3988 | Transferase | |
AZD3988 is an orally active and highly potent inhibitor of diacylglycerol acyltransferase-1 (DGAT-1) for the study of diabetes and obesity. | |||
T25978 | Pradigastat sodium | LCQ 908ABA,LCQ-908ABA,LCQ 908,LCQ-908,LCQ908ABA | |
Pradigastat sodium is a novel inhibitor of DGAT-1. | |||
T14085 | ABT-046 | Others | |
ABT-046 is an acyl CoA:diacylglycerol acyltransferase 1 (DGAT-1) inhibitor (IC50= 8 nM)[1] | |||
T62220 | DGAT1-IN-3 | ||
DGAT1-IN-3 is a selective, potent, orally active DGAT-1 inhibitor that inhibits human DGAT-1 (IC50: 38 nM) and rat DGAT-1 (IC50: 120 nM).DGAT1-IN-3 can be used in studies of obesity, dyslipidemia and metabolic syndrome. |